Aun, E., Teik, V. L. W., Linn, Y., Poon, M., Tan, L. K., Lee, J., han, H., LIM, Z. Y., Diong, C. P., Loh, Y., Leung, W., Koh, L. P. (2025). Haploidentical hematopoietic cell transplantation (Haplo-HCT) using ex vivo TCR-αβ–Depleted grafts and upfront memory T-cell add-back mitigates the negative impact of pre-transplant measurable residual disease (MRD) in adults with Acute Myeloid Leukemia (AML) and acute lymphoblastic leukemia (ALL) compared to matched related and unrelated donor transplantation. Blood. https://doi.org/10.1182/blood-2025-6020